Jinhua Wang, Ph.D. - Related publications

Affiliations: 
2006 Utah State University, Logan, UT, United States 
Area:
Organic Chemistry, Biochemistry, Immunology
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
36 most relevant papers in past 60 days:
Year Citation  Score
2021 Li J, Huang W, Han Q, Xiong J, Song Z. LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway. Medical Oncology (Northwood, London, England). 38: 2. PMID 33392788 DOI: 10.1007/s12032-020-01451-0   
2021 Zheng Q, Dong H, Mo J, Zhang Y, Huang J, Ouyang S, Shi S, Zhu K, Qu X, Hu W, Liu P, Wang Y, Zhang X. A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance. Theranostics. 11: 824-840. PMID 33391507 DOI: 10.7150/thno.49600   
2021 Hu W, Wu C, Yuan C, Chen M, Jin C, Zheng C. Ethanol Extracted from Radix of Actinidia Chinensis Inhibits Human Colon Tumor Through Inhibiting Notch-signaling Pathway. Journal of Cancer. 12: 622-629. PMID 33403022 DOI: 10.7150/jca.51275   
2021 Yang Y, Zhao M, Hu T, Su F, Qian F, Wang Z. Identification of an antitumor effect of demethylzeylasteral on human gastric cancer cells. Oncology Letters. 21: 49. PMID 33281960 DOI: 10.3892/ol.2020.12310   
2021 Byun WS, Bae ES, Park SC, Kim WK, Shin J, Lee SK. Antitumor Activity of Asperphenin B by Induction of Apoptosis and Regulation of Glyceraldehyde-3-phosphate Dehydrogenase in Human Colorectal Cancer Cells. Journal of Natural Products. PMID 33398999 DOI: 10.1021/acs.jnatprod.0c01155   
2021 Miao T, Peng C, Tang Z, Zeng M, Wang S, Wang X, Guo L, Wang X, Zhao J, Zhao M, Chen J, Liu C. Implication of Ataxia-Telangiectasia-mutated kinase in epithelium-mesenchyme transition. Carcinogenesis. PMID 33417668 DOI: 10.1093/carcin/bgab002   
2021 Konen JM, Rodriguez BL, Padhye A, Ochieng JK, Gibson L, Diao L, Fowlkes NW, Fradette JJ, Peng DH, Cardnell RJ, Kovacs JJ, Wang J, Byers LA, Gibbons DL. Dual inhibition of MEK and AXL targets tumor cell heterogeneity and prevents resistant outgrowth mediated by the epithelial-to-mesenchymal transition in NSCLC. Cancer Research. PMID 33402388 DOI: 10.1158/0008-5472.CAN-20-1895   
2021 Wu X, Jiang L, Zhang Z, He Y, Teng Y, Li J, Yuan S, Pan Y, Liang H, Yang H, Zhou P. Pancreatic cancer cell apoptosis is induced by a proteoglycan extracted from . Oncology Letters. 21: 34. PMID 33262826 DOI: 10.3892/ol.2020.12295   
2021 Chen GY, Zhang ZS, Chen Y, Li Y. Long non-coding RNA SNHG9 inhibits ovarian cancer progression by sponging microRNA-214-5p. Oncology Letters. 21: 80. PMID 33363617 DOI: 10.3892/ol.2020.12341   
2021 Ahmed MF, Santali EY, El-Haggar R. Novel piperazine-chalcone hybrids and related pyrazoline analogues targeting VEGFR-2 kinase; design, synthesis, molecular docking studies, and anticancer evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry. 36: 307-318. PMID 33349069 DOI: 10.1080/14756366.2020.1861606   
2021 Gnanamony M, Demirkhanyan L, Ge L, Sojitra P, Bapana S, Norton JA, Gondi CS. Circular dumbbell miR-34a-3p and -5p suppresses pancreatic tumor cell-induced angiogenesis and activates macrophages. Oncology Letters. 21: 75. PMID 33365086 DOI: 10.3892/ol.2020.12336   
2021 Mirzaei S, Gholami MH, Mahabady MK, Nabavi N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K, Makvandi P, Samarghandian S, Zarrabi A, Ashrafizadeh M, Khan H. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 133: 111077. PMID 33378975 DOI: 10.1016/j.biopha.2020.111077   
2021 Tsubaki M, Genno S, Takeda T, Matsuda T, Kimura N, Yamashita Y, Morii Y, Shimomura K, Nishida S. Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells. Biomedicines. 9. PMID 33406809 DOI: 10.3390/biomedicines9010035   
2021 Du J, Jiang F, Xu SS, Huang ZF, Chen LL, Li L. Tephrosin induces apoptosis of human pancreatic cancer cells through the generation of reactive oxygen species. Journal of Cancer. 12: 270-280. PMID 33391424 DOI: 10.7150/jca.50360   
2021 Sheng JQ, Wang MR, Fang D, Liu L, Huang WJ, Tian DA, He XX, Li PY. LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 133: 111023. PMID 33378941 DOI: 10.1016/j.biopha.2020.111023   
2021 Guo Q, Wu Y, Guo X, Cao L, Xu F, Zhao H, Zhu J, Wen H, Ju X, Wu X. The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B. Molecular Therapy. Nucleic Acids. 23: 169-184. PMID 33335801 DOI: 10.1016/j.omtn.2020.10.011   
2021 Li Y, Yuan R, Ren T, Yang B, Miao H, Liu L, Li Y, Cai C, Yang Y, Hu Y, Jiang C, Xu Q, Zhang Y, Liu Y. Role of Sciellin in gallbladder cancer proliferation and formation of neutrophil extracellular traps. Cell Death & Disease. 12: 30. PMID 33414368 DOI: 10.1038/s41419-020-03286-z   
2021 Xie H, Ma K, Zhang K, Zhou J, Li L, Yang W, Gong Y, Cai L, Gong K. Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway. Cell Death & Disease. 12: 1. PMID 33414393 DOI: 10.1038/s41419-020-03229-8   
2021 Xu J, Tan ZC, Shen ZY, Shen XJ, Tang SM. Cordyceps cicadae polysaccharides inhibit Human cervical cancer Hela cells proliferation via Apoptosis and Cell Cycle Arrest. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 111971. PMID 33421460 DOI: 10.1016/j.fct.2021.111971   
2021 Shi H, Sun X, Kong A, Ma H, Xie Y, Cheng D, Wong CKC, Zhou Y, Gu J. Cadmium induces epithelial-mesenchymal transition and migration of renal cancer cells by increasing PGE2 through a cAMP/PKA-COX2 dependent mechanism. Ecotoxicology and Environmental Safety. 207: 111480. PMID 33254385 DOI: 10.1016/j.ecoenv.2020.111480   
2021 Miura A, Sootome H, Fujita N, Suzuki T, Fukushima H, Mizuarai S, Masuko N, Ito K, Hashimoto A, Uto Y, Sugimoto T, Takahashi H, Mitsuya M, Hirai H. TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways. Investigational New Drugs. PMID 33409897 DOI: 10.1007/s10637-020-01019-9   
2021 Wang X, Zhang R, Wu T, Shi Y, Zhou X, Tang D, Yu W, So EC, Wu X, Pan Z, Tian J. Successive treatment with naltrexone induces epithelial-mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells. Acta Biochimica Et Biophysica Sinica. PMID 33410473 DOI: 10.1093/abbs/gmaa169   
2021 Lee HJ, Pham PC, Pei H, Lim B, Hyun SY, Baek B, Kim B, Kim Y, Kim MH, Kang NW, Min HY, Kim DD, Lee J, Lee HY. Development of the phenylpyrazolo[3,4-]pyrimidine-based, insulin-like growth factor receptor/Src/AXL-targeting small molecule kinase inhibitor. Theranostics. 11: 1918-1936. PMID 33408789 DOI: 10.7150/thno.48865   
2021 El-Sahli S, Hua K, Sulaiman A, Chambers J, Li L, Farah E, McGarry S, Liu D, Zheng P, Lee SH, Cui J, Ekker M, Côté M, Alain T, Li X, et al. A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature. Cell Death & Disease. 12: 8. PMID 33414428 DOI: 10.1038/s41419-020-03308-w   
2021 Niu L, Yang S, Zhao X, Liu X, Si L, Wei M, Liu L, Cheng L, Qiao Y, Chen Z. Sericin inhibits MDA‑MB‑468 cell proliferation via the PI3K/Akt pathway in triple‑negative breast cancer. Molecular Medicine Reports. 23. PMID 33313947 DOI: 10.3892/mmr.2020.11779   
2021 Liu Y, Song H, Zhou Y, Ma X, Xu J, Yu Z, Chen L. The oncogenic role of protein kinase D3 in cancer. Journal of Cancer. 12: 735-739. PMID 33403031 DOI: 10.7150/jca.50899   
2021 Han J, Liu Y, Yang S, Wu X, Li H, Wang Q. MEK inhibitors for the treatment of non-small cell lung cancer. Journal of Hematology & Oncology. 14: 1. PMID 33402199 DOI: 10.1186/s13045-020-01025-7   
2021 Wang L, Yang J, Wang HN, Fu RY, Liu XD, Piao YS, Wei LQ, Wang JW, Zhang L. LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma. Theranostics. 11: 925-940. PMID 33391513 DOI: 10.7150/thno.46655   
2021 Zhou J, Zhang S, Luo M. LncRNA promotes the malignant progression of breast cancer by regulating ErbB/PI3K/Akt pathway. Future Oncology (London, England). PMID 33401925 DOI: 10.2217/fon-2020-0273   
2021 Wang Q, Suo Y, Wang X, Wang Y, Tian X, Gao Y, Liu N, Liu R. Study on the mechanism of photodynamic therapy mediated by 5-aminoketovalerate in human ovarian cancer cell line. Lasers in Medical Science. PMID 33392781 DOI: 10.1007/s10103-020-03226-5   
2021 Zhao F, Wang P, Guo Y, Lu Q, Kong X, Su D, Li H, Liu G, Liu C. Identification of the potential roles of ring finger protein 8 in TP53-mutant breast cancer. Oncology Letters. 21: 42. PMID 33262834 DOI: 10.3892/ol.2020.12303   
2021 Sun D, Zong Y, Cheng J, Li Z, Xing L, Yu J. GINS2 attenuates the development of lung cancer by inhibiting the STAT signaling pathway. Journal of Cancer. 12: 99-110. PMID 33391406 DOI: 10.7150/jca.46744   
2021 Han Q, Zhang C, Zhang Y, Li Y, Wu L, Sun X. Bufarenogin induces intrinsic apoptosis via Bax and ANT cooperation. Pharmacology Research & Perspectives. 9: e00694. PMID 33421322 DOI: 10.1002/prp2.694   
2021 Zhou Q, Jin P, Liu J, Li S, Liu W, Xi S. HER2 overexpression triggers the IL-8 to promote arsenic-induced EMT and stem cell-like phenotypes in human bladder epithelial cells. Ecotoxicology and Environmental Safety. 208: 111693. PMID 33396024 DOI: 10.1016/j.ecoenv.2020.111693   
2021 Jonckheere S, Adams J, De Groote D, Campbell K, Berx G, Goossens S. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target. Cells, Tissues, Organs. 1-26. PMID 33401271 DOI: 10.1159/000512218   
2021 Panneerpandian P, Ganesan K. Development of a cell-based pathway modulator screening system to screen the targeted cancer therapeutic candidates. Human Cell. PMID 33405176 DOI: 10.1007/s13577-020-00476-x